How dosing might influence the conclusion in an antipsychotic polypharmacy effectiveness trial
Am J Psychiatry
.
2011 Oct;168(10):1117; author reply 1117.
doi: 10.1176/appi.ajp.2011.11050751.
Author
Lone Baandrup
PMID:
21969048
DOI:
10.1176/appi.ajp.2011.11050751
No abstract available
Publication types
Letter
Comment
MeSH terms
Antipsychotic Agents / therapeutic use*
Female
Humans
Male
Polypharmacy*
Schizophrenia / drug therapy*
Substances
Antipsychotic Agents